tiprankstipranks
Trending News
More News >
Invion (IVIXF)
OTHER OTC:IVIXF
Advertisement

Invion (IVIXF) Price & Analysis

Compare
35 Followers

IVIXF Stock Chart & Stats


Financials

IVIXF FAQ

What was Invion’s price range in the past 12 months?
Invion lowest stock price was $0.04 and its highest was $0.78 in the past 12 months.
    What is Invion’s market cap?
    Invion’s market cap is $6.07M.
      When is Invion’s upcoming earnings report date?
      Invion’s upcoming earnings report date is Aug 29, 2025 which is in 41 days.
        How were Invion’s earnings last quarter?
        Currently, no data Available
        Is Invion overvalued?
        According to Wall Street analysts Invion’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Invion pay dividends?
          Invion does not currently pay dividends.
          What is Invion’s EPS estimate?
          Invion’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Invion have?
          Invion has 84,875,800 shares outstanding.
            What happened to Invion’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Invion?
            Currently, no hedge funds are holding shares in IVIXF

            Invion Stock Smart Score

            Company Description

            Invion

            Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.
            Similar Stocks
            Company
            Price & Change
            Follow
            Elixinol Wellness
            Cann Group
            Ecofibre
            Epsilon Healthcare Limited
            Bod Australia Ltd
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis